Diseases, Conditions, Syndromes

US hoping for two COVID-19 vaccines by end of November

Two American companies expect to apply for emergency approval for their COVID-19 vaccines by late November, welcome news as the US crossed eight million confirmed cases amid a third surge of its coronavirus epidemic.

Diseases, Conditions, Syndromes

AstraZeneca, J&J vaccine trials back on track in US

Two major clinical trials for experimental COVID-19 vaccines got back on track in the United States Friday—providing a glimmer of hope as the number of cases skyrocket across the country.

Psychology & Psychiatry

Acute psychotic illness triggered by Brexit Referendum

Political events can take a serious toll on mental health, a doctor has warned in the journal BMJ Case Reports, after treating a man with a brief episode of acute psychosis, triggered by the 2016 Referendum on Brexit—the ...

Health

Obama asks Supreme Court to rule on health care

President Barack Obama's administration Wednesday asked the US Supreme Court to uphold his historic health care law, likely sparking an explosive legal showdown in the heat of the 2012 election.

Diseases, Conditions, Syndromes

Trump announces sixth vaccine contract, for 100 mn doses

President Donald Trump on Tuesday announced a $1.5 billion contract with US biotech company Moderna for 100 million doses of an eventual coronavirus vaccine, the sixth such deal reached since May.

Vaccination

Sinovac, AstraZeneca seek vaccine approval in Brazil

The manufacturers of two COVID-19 vaccines developed by Chinese pharmaceutical firm Sinovac and Oxford-AstraZeneca filed the first applications Friday for regulatory approval in hard-hit Brazil, officials said.

Diseases, Conditions, Syndromes

US prepares for pre-election COVID-19 vaccine rollout

The US has urged states to get ready for a potential COVID-19 vaccine rollout two days before the presidential election, it emerged Wednesday, as France prepared to present a mammoth spending plan for its virus-hit economy.

page 1 from 6